脱脂症和在HIV-1感染者中使用他类药物:超出降脂效应的范围
Gianluca Gazzaniga1, Marco Ridolfi2, Alessandro Lazzaro2
1Department of General Surgery and Surgical Specialty Paride Stefanini, Sapienza University of Rome, Rome, Italy; Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, Università degli Studi di Milano, Milan, Italy.
类固醇可以通过降低心血管风险和调节免疫力,使艾滋病毒-1 (PWH) 感染者受益. 然而,最佳使用需要针对HIV-1的特定目标和鉴定高风险子组,因为益处和药物相互作用的变化.
科学领域:
- 心血管健康 心血管健康
- 艾滋病毒-1管理管理
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于抗逆转录病毒疗法 (ART),HIV-1感染现在是一种慢性疾病.
- 携带HIV-1 (PWH) 的人面临并发症的风险增加,尤其是心血管事件.
- 脱脂症是PWH中心血管事件的重要多因素风险因素.
研究的目的:
- 审查PWH中脱脂症的多因素原因.
- 为了检查他类药物和ART之间的药物相互作用.
- 在PWH中探索他类药物的抗炎和免疫调节作用.
主要方法:
- 现有文献的叙述性审查.
- 对PWH中他类药物的疗效和安全性研究的分析.
- 检查他类药物的非降脂性质.
主要成果:
- 类固醇药物治疗可能会降低PWH的死亡率和心血管风险,但好处各不相同.
- 静止剂的益处似乎取决于HIV-1暴露时间和ART类型.
- 由于对药物相互作用的担忧,他类药物的剂量往往不足;它们具有抗炎和免疫调节作用.
结论:
- 通过降低LDL胆固醇和免疫调节,他类药物在PWH中提供了潜在的益处.
- 需要针对HIV-1特定的LDL胆固醇标来应对过度的心血管风险.
- 识别高危子组对于优化PWH中他类药物治疗至关重要.
更多相关视频
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Sexually Transmitted Infections
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
